USARx offers multiple ways to purchase this medication. Choose the Best option for you!
Note: This document contains side effect information about brimonidine topical. Some of the dosage forms listed on this page may not apply to the brand name Mirvaso.
Common side effects of Mirvaso include: flushing. Other side effects include: burning sensation of skin and erythema of skin. See below for a comprehensive list of adverse effects.
Applies to brimonidine topical: topical application gel/jelly
Along with its needed effects, brimonidine topical (the active ingredient contained in Mirvaso) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking brimonidine topical:
Some side effects of brimonidine topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to brimonidine topical: topical gel
The most commonly reported adverse reactions are headache, erythema, pruritus, flushing and skin burning sensation.
Common (1% to 10%): Acne, allergic contact dermatitis, contact dermatitis, dermatitis, erythema, pruritus, rosacea, skin burning sensation, skin irritation, skin pain, warm skin
Uncommon (0.1% to 1%): Dry skin, skin discomfort, papular rash
Postmarketing reports: Aggravated erythema, face swelling, pallor, urticaria
Common (1% to 10%): Nasal congestion, nasopharyngitis, upper respiratory track infection
Postmarketing reports: Throat tightness
Common (1% to 10%): Blurred vision, increased intraocular pressure
Uncommon (0.1% to 1%): Eyelid edema
Common (1% to 10%): Headache, paresthesia
Postmarketing reports: Dizziness
Common (1% to 10%): Flushing
Postmarketing reports: Bradycardia, hypotension, orthostatic hypotension
Uncommon (0.1% to 1%): Feeling hot, peripheral coldness
Uncommon (0.1% to 1%): Dry mouth
Postmarketing reports: Lip swelling, tongue swelling
Postmarketing reports: Angioedema, hypersensitivity
Postmarketing reports: Application site pallor, excessive whitening at application site
June 26, 2020
June 25, 2020
June 27, 2020
July 10, 2020
July 9, 2020
July 1, 2020